Marrone Bio Innovations (NASDAQ:MBII) Upgraded by Zacks Investment Research to Hold

Marrone Bio Innovations} stock has undergone multiple analysts rating changes in the recent past.  Marrone Bio Innovations Upgraded by Zacks Investment Research on 10/20/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Sell.

View More Marrone Bio Innovations (NASDAQ:MBII) Upgraded by Zacks Investment Research to Hold